[
    [
        {
            "time": "2020-06-24",
            "original_text": "康泰生物：乙肝疫苗生产基地变更获批 2020年底有望实现批签发",
            "features": {
                "keywords": [
                    "康泰生物",
                    "乙肝疫苗",
                    "生产基地变更",
                    "批签发"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：乙肝疫苗生产基地变更获批 2020年底有望实现批签发",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-24",
            "original_text": "医药行业半年度策略报告：紧抓“抗疫”和“自主定价”两大主线",
            "features": {
                "keywords": [
                    "医药行业",
                    "策略报告",
                    "抗疫",
                    "自主定价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业半年度策略报告：紧抓“抗疫”和“自主定价”两大主线",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-24",
            "original_text": "康泰生物现1笔大宗交易 共成交5,945.09万元",
            "features": {
                "keywords": [
                    "康泰生物",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物现1笔大宗交易 共成交5,945.09万元",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-24",
            "original_text": "医药生物行业2020年中期策略：拥抱疫情后周期投资机会 重点关注医药新基建和医药大消费",
            "features": {
                "keywords": [
                    "医药生物",
                    "疫情后周期",
                    "医药新基建",
                    "医药大消费"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业2020年中期策略：拥抱疫情后周期投资机会 重点关注医药新基建和医药大消费",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-24",
            "original_text": "新冠疫苗又进一步！这个试验Ⅲ期启动，相关股票6天大涨近50%",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "试验Ⅲ期",
                    "股票上涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠疫苗又进一步！这个试验Ⅲ期启动，相关股票6天大涨近50%",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-24",
            "original_text": "康泰生物：乙肝疫苗获药品补充申请批件 批量生产在即",
            "features": {
                "keywords": [
                    "康泰生物",
                    "乙肝疫苗",
                    "药品补充申请批件",
                    "批量生产"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：乙肝疫苗获药品补充申请批件 批量生产在即",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-24",
            "original_text": "上证综指半日升0.15%，半导体概念股板块大涨稳定市场",
            "features": {
                "keywords": [
                    "上证综指",
                    "半导体概念",
                    "市场稳定"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "半导体"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上证综指半日升0.15%，半导体概念股板块大涨稳定市场",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-24",
            "original_text": "创业板指小幅回调，爱尔眼科、康泰生物、迈克生物、康龙化成领跌",
            "features": {
                "keywords": [
                    "创业板指",
                    "回调",
                    "康泰生物",
                    "领跌"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "创业板指小幅回调，爱尔眼科、康泰生物、迈克生物、康龙化成领跌",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]